HUP9901051A2 - 5-(2-Etil-2H-tetrazol-5-il)-1,2,3,6-tetrahidro-1-metil-piridin alkalmazása traumás agykárosodások kezelésére alkalmas gyógyászati készítmények előállítására - Google Patents
5-(2-Etil-2H-tetrazol-5-il)-1,2,3,6-tetrahidro-1-metil-piridin alkalmazása traumás agykárosodások kezelésére alkalmas gyógyászati készítmények előállításáraInfo
- Publication number
- HUP9901051A2 HUP9901051A2 HU9901051A HUP9901051A HUP9901051A2 HU P9901051 A2 HUP9901051 A2 HU P9901051A2 HU 9901051 A HU9901051 A HU 9901051A HU P9901051 A HUP9901051 A HU P9901051A HU P9901051 A2 HUP9901051 A2 HU P9901051A2
- Authority
- HU
- Hungary
- Prior art keywords
- treatment
- traumatic brain
- tetrazol
- tetrahydro
- ethyl
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 208000030886 Traumatic Brain injury Diseases 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 230000009529 traumatic brain injury Effects 0.000 title 1
- 208000003174 Brain Neoplasms Diseases 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 230000000472 traumatic effect Effects 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- RNMOMKCRCIRYCZ-UHFFFAOYSA-N Alvameline Chemical compound CCN1N=NC(C=2CN(C)CCC=2)=N1 RNMOMKCRCIRYCZ-UHFFFAOYSA-N 0.000 abstract 1
- 206010008088 Cerebral artery embolism Diseases 0.000 abstract 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 abstract 1
- 206010008132 Cerebral thrombosis Diseases 0.000 abstract 1
- 206010010254 Concussion Diseases 0.000 abstract 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 abstract 1
- 206010022773 Intracranial pressure increased Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000009514 concussion Effects 0.000 abstract 1
- 201000002491 encephalomyelitis Diseases 0.000 abstract 1
- 230000004217 heart function Effects 0.000 abstract 1
- 208000003906 hydrocephalus Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 201000010849 intracranial embolism Diseases 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 230000029058 respiratory gaseous exchange Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000003625 skull Anatomy 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK123295 | 1995-11-06 | ||
| PCT/DK1996/000458 WO1997017074A1 (en) | 1995-11-06 | 1996-11-05 | Treatment of traumatic brain injury |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP9901051A2 true HUP9901051A2 (hu) | 2000-03-28 |
Family
ID=8102484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9901051A HUP9901051A2 (hu) | 1995-11-06 | 1996-11-05 | 5-(2-Etil-2H-tetrazol-5-il)-1,2,3,6-tetrahidro-1-metil-piridin alkalmazása traumás agykárosodások kezelésére alkalmas gyógyászati készítmények előállítására |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0866706A1 (de) |
| JP (1) | JPH11514654A (de) |
| KR (1) | KR19990067353A (de) |
| AU (1) | AU706594B2 (de) |
| BG (1) | BG63150B1 (de) |
| BR (1) | BR9611396A (de) |
| CA (1) | CA2234824A1 (de) |
| CZ (1) | CZ287441B6 (de) |
| EA (1) | EA000531B1 (de) |
| HU (1) | HUP9901051A2 (de) |
| IS (1) | IS4726A (de) |
| NO (1) | NO982036L (de) |
| NZ (1) | NZ321546A (de) |
| PL (1) | PL326490A1 (de) |
| SK (1) | SK58198A3 (de) |
| TR (1) | TR199800801T2 (de) |
| WO (1) | WO1997017074A1 (de) |
| ZA (1) | ZA969320B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR013096A1 (es) * | 1997-07-01 | 2000-12-13 | Lundbeck & Co As H | Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma. |
| EP2258358A3 (de) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenese mit Acetylcholinesterasehemmer |
| US7678363B2 (en) | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
| EP1940389A2 (de) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation von neurogenese durch pde-hemmung |
| US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| US5328925A (en) * | 1989-02-22 | 1994-07-12 | Novo Nordisk A/S | Piperidine compounds and their use |
| IE922270A1 (en) * | 1991-07-26 | 1993-01-27 | Akzo Nv | Pyrazole derivatives |
| US5330994A (en) * | 1992-03-24 | 1994-07-19 | Warner-Lambert Company | Tetrahydropyridine isoxazoline derivatives |
-
1996
- 1996-11-05 JP JP9517762A patent/JPH11514654A/ja active Pending
- 1996-11-05 CA CA002234824A patent/CA2234824A1/en not_active Abandoned
- 1996-11-05 AU AU74900/96A patent/AU706594B2/en not_active Ceased
- 1996-11-05 SK SK581-98A patent/SK58198A3/sk unknown
- 1996-11-05 HU HU9901051A patent/HUP9901051A2/hu unknown
- 1996-11-05 KR KR1019980703360A patent/KR19990067353A/ko not_active Application Discontinuation
- 1996-11-05 PL PL96326490A patent/PL326490A1/xx unknown
- 1996-11-05 NZ NZ321546A patent/NZ321546A/xx unknown
- 1996-11-05 TR TR1998/00801T patent/TR199800801T2/xx unknown
- 1996-11-05 BR BR9611396A patent/BR9611396A/pt not_active Application Discontinuation
- 1996-11-05 EP EP96937193A patent/EP0866706A1/de not_active Ceased
- 1996-11-05 WO PCT/DK1996/000458 patent/WO1997017074A1/en not_active Application Discontinuation
- 1996-11-05 EA EA199800434A patent/EA000531B1/ru not_active IP Right Cessation
- 1996-11-05 CZ CZ19981389A patent/CZ287441B6/cs not_active IP Right Cessation
- 1996-11-06 ZA ZA969320A patent/ZA969320B/xx unknown
-
1998
- 1998-04-27 IS IS4726A patent/IS4726A/is unknown
- 1998-05-05 NO NO982036A patent/NO982036L/no not_active Application Discontinuation
- 1998-05-22 BG BG102480A patent/BG63150B1/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2234824A1 (en) | 1997-05-15 |
| ZA969320B (en) | 1997-05-30 |
| JPH11514654A (ja) | 1999-12-14 |
| EA000531B1 (ru) | 1999-10-28 |
| PL326490A1 (en) | 1998-09-28 |
| BR9611396A (pt) | 1999-07-13 |
| EP0866706A1 (de) | 1998-09-30 |
| EA199800434A1 (ru) | 1998-10-29 |
| AU706594B2 (en) | 1999-06-17 |
| NZ321546A (en) | 2000-12-22 |
| CZ138998A3 (cs) | 1998-10-14 |
| SK58198A3 (en) | 1998-10-07 |
| NO982036D0 (no) | 1998-05-05 |
| WO1997017074A1 (en) | 1997-05-15 |
| MX9803432A (es) | 1998-09-30 |
| TR199800801T2 (xx) | 1998-08-21 |
| NO982036L (no) | 1998-06-25 |
| IS4726A (is) | 1998-04-27 |
| CZ287441B6 (en) | 2000-11-15 |
| BG63150B1 (bg) | 2001-05-31 |
| AU7490096A (en) | 1997-05-29 |
| KR19990067353A (ko) | 1999-08-16 |
| BG102480A (en) | 1999-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Walker et al. | Convulsive factor in commercial penicillin | |
| HUP9901051A2 (hu) | 5-(2-Etil-2H-tetrazol-5-il)-1,2,3,6-tetrahidro-1-metil-piridin alkalmazása traumás agykárosodások kezelésére alkalmas gyógyászati készítmények előállítására | |
| HUP9904525A2 (hu) | S-(-)-N-Propargil-1-amino-indán tartalmú neurológiai rendellenességek kezelésére alkalmas gyógyszerkészítmények | |
| DE3876877D1 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
| CY1105507T1 (el) | Υποκατεστημενες πυραζολο- και θειαζολοπυριμιδινες | |
| HUP0105027A2 (hu) | N-Heterociklusos vegyületek karbonsavszármazékai és karbonsav-izoszterei és alkalmazásuk | |
| ES2001801A6 (es) | Procedimiento para la preparacion de nuevas amidas e hidrazidas del acido (2,3,9,9a-tetrahidro-3-oxo-9a-sustituyente-ih-fluoren-7-il)oxi) etanimidico, sus sales y derivados. | |
| NZ234672A (en) | N-(1,2,3,4-tetrahydro-9-acridinyl)amide and carbamate derivatives and pharmaceutical compositions | |
| ATE82294T1 (de) | Therapeutische nukleoside. | |
| NO903384D0 (no) | Fremgangsmaate for fremstilling av 4-(n-substituert amino)-2-butynyl-1-urinstoffer og -tiourinstoffer og derivater derav. | |
| Lienemann et al. | Naltrexone for treatment of self-injury. | |
| GR3022205T3 (en) | New derivatives of physostigmine, their use and pharmaceutical formulations containing them | |
| TR199901304A2 (xx) | Spiro $Piperidin-4,1'-Pirrolo $3,4-c]Pirrol ] | |
| NO892152D0 (no) | Kondenserte diazepinoner, fremstilling derav og legemidler som inneholder dem. | |
| ZA891769B (en) | Heterocyclic compounds | |
| Gould et al. | Electrocardiographic normalization after cerebral vascular accident | |
| ATE268599T1 (de) | Verwendung von beta-naphtaquinon derivaten zur herstellung eines arzneimittels mit einem hemmenden effekt auf die glutamatfreisetzung durch das gehirn | |
| ATE207353T1 (de) | Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden | |
| NO20013480L (no) | Legemiddel for torr hud | |
| Small et al. | " Topographic brain mapping: Applications and pitfalls": Commentary. | |
| Smith | MENINGITIS: ITS SYMPTOMATOLOGY, DIAGNO-SIS AND TREATMENT, WITH REPORT OF A CASE. | |
| Shiraishi et al. | Hyperbaric Oxygenation Therapy for Idiopathic Sudden Sensory Neural Hearing Loss Experience of Use of PGE 1 | |
| RU93008090A (ru) | Способ лечения глубоких отморожений кисти | |
| RU93054219A (ru) | Способ лечения осложнений фронтально-базальных повреждений черепа и головного мозга |